Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, 2050, Australia.
School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, 2050, Australia.
Sci Rep. 2024 Aug 7;14(1):18331. doi: 10.1038/s41598-024-69393-5.
Spinal and bulbar muscular atrophy (SBMA), or Kennedy's disease (KD), is a rare hereditary neuromuscular disorder demonstrating commonalities with amyotrophic lateral sclerosis (ALS). The current study aimed to define functional and central nervous system abnormalities associated with SBMA pathology, their interaction, and to identify novel clinical markers for quantifying disease activity. 27 study participants (12 SBMA; 8 ALS; 7 Control) were recruited. SBMA patients underwent comprehensive motor and sensory functional assessments, and neurophysiological testing. All participants underwent whole-brain structural and diffusion MRI. SBMA patients demonstrated marked peripheral motor and sensory abnormalities across clinical assessments. Increased abnormalities on neurological examination were significantly associated with increased disease duration in SBMA patients (R = 0.85, p < 0.01). Widespread juxtacortical axonal degeneration of corticospinal white matter tracts were detected in SBMA patients (premotor; motor; somatosensory; p < 0.05), relative to controls. Increased axial diffusivity was significantly correlated with total neuropathy score in SBMA patients across left premotor (R = 0.59, p < 0.01), motor (R = 0.63, p < 0.01), and somatosensory (R = 0.61, p < 0.01) tracts. The present series has identified involvement of motor and sensory brain regions in SBMA, associated with disease duration and increasing severity of peripheral neuropathy. Quantification of annualized brain MRI together with Total Neuropathy Score may represent a novel approach for clinical monitoring.
脊髓延髓肌肉萎缩症(SBMA),又称肯尼迪病(KD),是一种罕见的遗传性神经肌肉疾病,与肌萎缩侧索硬化症(ALS)有共同之处。本研究旨在确定与 SBMA 病理学相关的功能和中枢神经系统异常、它们的相互作用,并确定用于量化疾病活动的新的临床标志物。招募了 27 名研究参与者(12 名 SBMA;8 名 ALS;7 名对照组)。SBMA 患者接受了全面的运动和感觉功能评估以及神经生理学测试。所有参与者都接受了全脑结构和弥散 MRI 检查。SBMA 患者在临床评估中表现出明显的周围运动和感觉异常。在 SBMA 患者中,神经系统检查中异常的增加与疾病持续时间的增加显著相关(R = 0.85,p < 0.01)。与对照组相比,SBMA 患者中皮质脊髓白质束的皮质下轴突广泛变性(运动前;运动;感觉;p < 0.05)。在 SBMA 患者中,轴向弥散度的增加与总神经病变评分显著相关,涉及左侧运动前(R = 0.59,p < 0.01)、运动(R = 0.63,p < 0.01)和感觉(R = 0.61,p < 0.01)束。本系列研究确定了 SBMA 中运动和感觉脑区的受累,与疾病持续时间和周围神经病变的严重程度增加有关。年度化脑 MRI 与总神经病变评分的定量可能代表一种新的临床监测方法。